From Molecules to Mind: The Critical Role of Chitosan, Collagen, Alginate, and Other Biopolymers in Neuroprotection and Neurodegeneration
От молекул к разуму: критическая роль хитозана, коллагена, альгината и других биополимеров в нейропротекции и нейродегенерации
2025-02-22
SCID: 54.1/beqa8kcb
Discuss with AI
AlginateBiopolymer-based drug deliveryBlood-brain barrierChitosanCollagen/gelatin
Figures from the paper
Abstract (AI)
Neurodegenerative disorders present significant therapeutic challenges, particularly due to the complex nature of drug delivery to the central nervous system. This review investigates the applications of various biopolymers in neuroprotection and their potential role in treating neurodegeneration. We present a critical analysis of natural and synthetic biopolymers, focusing primarily on chitosan, fish collagen/gelatin, and alginate as key therapeutic agents. The review examines the fundamental mechanisms of brain development and neurodegeneration, establishing a framework for understanding how these biopolymers interact with neural tissues. By analyzing recent experimental studies, we evaluate the effectiveness of different biopolymer-based delivery systems in crossing the blood-brain barrier and their subsequent neuroprotective effects. Additionally, promising materials, including lignin, poly lactic-co-glycolic acid, and glucose-modified bovine serum albumin/procyanidin complexes, are briefly explored to provide a comprehensive overview of current developments in the field. Our analysis reveals that biopolymer-based approaches offer unique advantages in both neuroprotection and drug delivery, potentially opening new avenues for treating neurodegenerative conditions. This review synthesizes current knowledge and identifies promising directions for future research in biopolymer-based therapeutic strategies.
Key Findings
1
Biopolymer strategies may expand treatment options for neurodegenerative disorders, although further research is needed to advance these approaches.
2
Biopolymer-based delivery systems are assessed for their ability to cross the blood-brain barrier and produce neuroprotective effects.
3
Chitosan, collagen/gelatin, and alginate offer potential therapeutic advantages through interactions with neural tissues and drug-delivery functions.
4
Lignin, poly(lactic-co-glycolic acid), and glucose-modified bovine serum albumin/procyanidin complexes represent additional promising materials for neurodegenerative applications.
5
The review evaluates natural and synthetic biopolymers, emphasizing chitosan, fish collagen/gelatin, and alginate for neuroprotection and neurodegeneration therapy.
Research Object
Natural and synthetic biopolymers, particularly chitosan, fish collagen/gelatin, alginate, lignin, poly lactic-co-glycolic acid, and glucose-modified bovine serum albumin/procyanidin complexes, for CNS applications
Research Subject
Biopolymer-based drug delivery across the blood–brain barrier and neuroprotective effects relevant to neurodegenerative disorders
Publication Details
Publication Date
2025-02-22
Journal
Publisher
ISSN
Cited by
24
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai5
The blood–brain barrier: Structure, regulation and drug delivery2023
Structures, Properties and Applications of Alginates2022
Biopolymer: A Sustainable Material for Food and Medical Applications2022
Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges2019
Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs2020